(Allergan plc)

	AGN latest price $122.2700 (-0.46%) ($121.9200 - $124.5900) on Wed. Jun. 12, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.73% (three month average)
RSI	25
Latest Price	$122.2700(-0.46%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.7% a day on average for past five trading days.
Weekly Trend	AGN declines -3.3% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(47%)    XLV(46%)    ARKG(45%)    EWP(45%)    IVE(45%)
Factors Impacting AGN price	AGN will decline at least -0.865% in a week (0% probabilities).   VXX(-38%)    TLT(-22%)    IFRA(-21%)    GDX(-5%)    BWX(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.865% (StdDev 1.73%)
Hourly BBV	0 ()
Intraday Trend	-0.8%

Resistance Level	$130.17
5 Day Moving Average	$124.78(-2.01%)
10 Day Moving Average	$124.67(-1.93%)
20 Day Moving Average	$130.17(-6.07%)
To recent high	-20.7%
To recent low	0.3%
Market Cap	$40.312b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed